Stockreport
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
Stephen MacMillan to retire from the BoardSAN DIEGO, March 25, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, founder, Managing Partner, and Chief Investment Officer of Corvex Management, will join the Board of Directors on March 28, 2025. Stephen MacMillan, Chairman, President, and CEO of Hologic, who joined the Illumina Board in June 2023, has decided to retire from the board in preparation for the company's upcoming annual meeting of shareholders."I'm honored to accept this role at Illumina, a company at the forefront of our rapidly evolving industry, whose groundbreaking innovations continue to transform patient opportunities and shape the field of genomics," Dr. Gottlieb said. "I extend our grati
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors [Yahoo! Finance][Yahoo! Finance]
- Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery[PR Newswire]
- Computational Biology Market Projected to Reach USD 25.46 Billion by 2032 at 16.80% CAGR, Driven by AI and Genomic Research – SNS Insider [Yahoo! Finance][Yahoo! Finance]
- Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Royal Bank of Canada from $247.00 to $128.00. They now have an "outperform" rating on the stock.[MarketBeat]
- Illumina, Inc. (NASDAQ: ILMN) had its "underweight" rating re-affirmed by analysts at Barclays PLC.[MarketBeat]
- More
ILMN
SEC Filings
SEC Filings
- 3/25/25 - Form 8-K
- 3/24/25 - Form 8-K
- 3/10/25 - Form 8-K
- ILMN's page on the SEC website
- More